Dry Eye Syndrome Treatment Market Growth, Sales, Outlook and Cost Structure Till 2027

Market Overview

 During the forthcoming years, the Dry Eye Syndrome Treatment Market is expected to grow rapidly, as it has in recent years. A large percentage of the world’s population suffers from dry eye disease (from middle age to elderly age). According to the World Aging 2020 report, 727 million people aged 65 and up will be alive in 2020. This population is estimated to increase 1.5 billion by 2050. The elderly number is expected to rise, necessitating additional accommodations.

 The outbreak of the COVID-19 pandemic in 2020 disrupted healthcare systems by posing a number of challenges, as well as to ophthalmology practice. In most countries, however, immediate and vital treatments were permitted. During the COVID-19 pandemic, the American Society of Retina Specialists released guidelines to help retina practises and medical personnel reduce risk and ensure patient health and safety.

 During this period of severely restricted operating theater access, the guidelines outline the important visits for patients and provide a way to categorize emergent, urgent and non-urgent, and non-elective cases. Giuseppe Giannaccare et al. distributed a survey titled “COVID-19” to 200 students were randomly selected attending the Faculty of Medicine of the University Magna Graecia in order to investigate the pervasiveness of ocular discomfort symptoms related to DED during the COVID-19 pandemic (Catanzaro, Italy). Graefe’s Archive for Clinical and Experimental Ophthalmology published the study in June 2020. Patients with dry eye disease were also affected due to a lapse in follow-ups.

 Keratoconjunctivitis sicca (KCS), also known as dry eye syndrome, is a situation in which the floor of the impacted person’s eyes lacks lubrication or humidity. It’s a common affliction that can strike at any time. Dry eye symptoms include aching and burning sensations, sore eyes, red eyes, tired eyes, itchy eyes, photophobia, and other symptoms. Watery eyes are another symptom, as the dry surface of the eyes stimulates the manufacturing of the watery element of tears to compensate for the drying.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5588

 Market Segmentation

 By Drug type

• Tear-stimulating drugs
• Topical Corticosteroids
• Immunosuppressive drugs
• Artificial Tears
• Others

By Mode of Administration

• Oral
• Topical

By Distribution channel

• Hospital pharmacies
• Retail pharmacies
• Specialty clinics
• e-commerce
• Others

By Countries

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Asia Pacific
• Japan
• China
• India
• Australia
• Latin America
• Mexico
• Brazil
• Argentina
• Middle East and Africa
• South Africa
• GCC Countries

 Regional Classification

 The size of the dry eye market in North America will grow due to the rising prevalence of thyroid disorders in the region. According to the American Thyroid Association, more than 12% of the population in the United States will develop a thyroid condition at some point in their lives, which could boost market dynamics because thyroid disease is a major cause of decreased tear production.

 Industry News

 Ceqa, a calcineurin inhibitor, has been introduced by Sun Pharma Canada Inc, a wholly-owned division of Sun Pharmaceutical Industries. The product is the first dry eye treatment in Canada to use nanomicellar (NCELL) technology, which improves cyclosporine bioactivity and chemical stability to enhance ocular tissue penetration.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/dry-eye-syndrome-market-5588 

 Competitive Landscape

The major global companies playing a key role in the dry eye syndrome market are:

• Allergan (Republic of Ireland)
• Novartis AG (Switzerland),
• Otsuka Pharmaceutical Co. Ltd. (Japan)
• Valent Pharmaceuticals (Canada)
• Johnson & Johnson Vision (U.S.)
• Acadia Pharmaceutical (U.S.)
• Allostera Pharma (Canada)
• I-Med Pharma Inc. (Canada)
• Santen Pharmaceuticals Co. Ltd., (Japan)
• AFT Pharmaceuticals (New Zealand)
• Novaliq GmBh (Germany)
• Auven therapeutics (U.S.)

Browse Related Reports at:

Global Post-Operative Pain Management Market Research Report – Forecast to 2027

Global Neuropsychiatric Disorders and Treatment Market Research Report– Forecast To 2027

Global Optogenetics Market Research Report – Forecast to 2027

Global Apheresis Market Research Report – Forecast To 2027

Global Prostate cancer Market Research Report – Forecast To 2027

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Tags: Dry Eye Syndrome Treatment Market 2022, Dry Eye Syndrome Treatment market size, Dry Eye Syndrome Treatment market share See Campaign: https://www.marketresearchfuture.com

Contact Information:

Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013 United States of America +1 628 258 0071 Email: [email protected]

Tags:
Wire, Research Newswire, English